| Preview | Company (Stock code) | Date/time | Event | Presenter |
|---|---|---|---|---|
 | INVION LIMITED (IVX) | Tue, 06 Oct 2015 11:45 am (UK time) | Invion successfully completes phase II study of INV02 (Nadolol) to aid smoking cessation |
|
 | INVION LIMITED (IVX) | Tue, 18 Aug 2015 12:45 pm (UK time) | Dr Mitchell Glass discusses Invion's phase II lupus clinical results |
|
| | INVION LIMITED (IVX) | Tue, 19 May 2015 11:30 am (UK time) | Invion update on INV102 (oral nadolol) |
|
 | INVION LIMITED (IVX) | Mon, 19 Jan 2015 10:00 am (UK time) | Invion Interim Smoking Cessation Data Update |
|
| | INVION LIMITED (IVX) | Tue, 23 Sep 2014 10:00 am (UK time) | Invion: Phase 2 INV102 trial Update |
|
| | INVION LIMITED (IVX) | Mon, 08 Sep 2014 03:00 pm (UK time) | Invion Ltd. Lupus Clinical Trial update |
|
 | INVION LIMITED (IVX) | Tue, 17 Jun 2014 11:00 pm (UK time) | Invion Limited Investor briefing ASX:IVX |
|
| | INVION LIMITED (IVX) | Fri, 21 Feb 2014 02:45 am (UK time) | Invion announces a significant agreement with 3M Drug Delivery Systems |
|